PMC5477908_01
Clinical course of proteinuria after third relapse of FSGS and response to plasma exchange (PE) and rituximab.
sfm048fig1.jpg
PMC5477908_01_sfm048fig1.jpg
F1
Although treatment with PE induced a remission of proteinuria, repeated trials of cessation of PE failed (Figure 1). Nine months later, she experienced a relapse of proteinuria (Figure 1).
PMC5477908_02
PMC5477908_03
PMC5477908_04